Geron Corporation (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Geron Corporation" in English language version.

refsWebsite

Global rank English rank

10nih.gov

4^th place

8doi.org

2^nd place

6web.archive.org

1^st place

4bizjournals.com

407^th place

241^st place

2nytimes.com

7^th place

2harvard.edu

18^th place

17^th place

2archive.today

14^th place

2clinicaltrials.gov

5,225^th place

4,062^nd place

2semanticscholar.org

11^th place

8^th place

2forbes.com

54^th place

48^th place

2nature.com

234^th place

397^th place

1sec.report

low place

1newscientist.com

774^th place

716^th place

1edgar-online.com

low place

1mercurynews.com

701^st place

439^th place

1worldcat.org

5^th place

1bio.net

low place

1latimes.com

22^nd place

19^th place

1money.com

9,129^th place

4,880^th place

1cancer.gov

1,684^th place

1,350^th place

1fool.com

4,183^rd place

2,600^th place

1bioworld.com

low place

1geron.com

low place

1globenewswire.com

2,614^th place

1,549^th place

1fiercebiotech.com

low place

8,828^th place

1zacks.com

low place

1cycloastragenol.com

low place

1escholarship.org

1,523^rd place

976^th place

1genengnews.com

low place

6,625^th place

1yahoo.com

38^th place

40^th place

1scimitarequity.com

low place

1the-scientist.com

7,827^th place

5,905^th place

1badgerherald.com

low place

9,803^rd place

1wsj.com

79^th place

65^th place

1science.org

1,160^th place

737^th place

1genetics-and-society.org

low place

1warf.org

low place

1sandiegouniontribune.com

1,275^th place

722^nd place

1pubpat.org

low place

1businessweek.com

712^th place

526^th place

1gpo.gov

1,360^th place

845^th place

archive.today

"Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat". Investor Relations: Press Release. Geron. Archived from the original on September 5, 2015. Retrieved 2018-02-25.
CNN Rachel Meade Reports (October 13, 2010)

badgerherald.com

Westhoff, Julia (22 January 2002). "WARF, Geron reach settlement". The Badger Herald.

bio.net

"Geron Corporation 10K 1996".

bioworld.com

Fitzhugh, Michael (17 November 2014). "'New chapter' as Geron lands potential $935M imetelstat deal with Janssen". BioWorld.

bizjournals.com

Leuty, Ron (30 September 2011). "Chip Scarlett's skills may pay off – again – at Geron". San Francisco Business Times. Retrieved 15 November 2016.
"Geron plans stock offering, Merck buying $18M in shares". 12 September 2005.
Ron Leuty (November 15, 2012). "Geron to sell embryonic stem cell business to BioTime". San Francisco Business Times. Retrieved 2020-12-14.
"BioTime acquires stem cell assets from Geron, raises $10 million". San Francisco Business Times. January 7, 2013.

businessweek.com

"Online Extra: Thomas Okarma: Don't Ban Stem-Cell Research". BusinessWeek. 2 June 2003. Archived from the original on 22 May 2011.

cancer.gov

"Imetelstat Sodium". NCI Drug Dictionary. National Cancer Institute. Retrieved 15 November 2016.

clinicaltrials.gov

Geron Corporation (2021-01-04). "A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment". Clinical Trials.
Geron Corporation (2020-12-23). "A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients With Intermediate-2 or High-risk Myelofibrosis (MF) Refractory to Janus Kinase (JAK)-Inhibitor". Clinical Trials.

cycloastragenol.com

American Analytical Chemistry Laboratories Analysis Document #100710-236 of TA-65

doi.org

Hayflick L (1965). "The limited in vitro lifetime of human diploid cell strains". Experimental Cell Research. 37 (3): 614–636. doi:10.1016/0014-4827(65)90211-9. PMID 14315085.
Brennan, Sarah K.; Wang, Qiuju; Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina; Huff, Carol Ann; Jones, Richard J.; Matsui, William; Swarbrick, Alexander (1 September 2010). "Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms". PLOS ONE. 5 (9): e12487. Bibcode:2010PLoSO...512487B. doi:10.1371/journal.pone.0012487. PMC 2931698. PMID 20824134.
Harley, Calvin B. (March 2008). "Telomerase and cancer therapeutics". Nature Reviews Cancer. 8 (3): 167–179. doi:10.1038/nrc2275. PMID 18256617. S2CID 39599576.
Fauce, Steven Russell; Jamieson, Beth D.; Chin, Allison C.; Mitsuyasu, Ronald T.; Parish, Stan T.; Ng, Hwee L.; Ramirez Kitchen, Christina M.; Yang, Otto O.; Harley, Calvin B.; Effros, Rita B. (2008). "Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8⁺ T Lymphocytes". The Journal of Immunology. 181 (10): 7400–7406. doi:10.4049/jimmunol.181.10.7400. PMC 2682219. PMID 18981163.
Borrell, Brendan (2 August 2012). "Lawsuit challenges anti-ageing claims". Nature. 488 (7409): 18. Bibcode:2012Natur.488...18B. doi:10.1038/488018a. PMID 22859181.
Keirstead HS, Nistor G, Bernal G, et al. (May 2005). "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury". J. Neurosci. 25 (19): 4694–705. doi:10.1523/JNEUROSCI.0311-05.2005. PMC 6724772. PMID 15888645.
Kintisch, E. (21 July 2006). "Groups Challenge Key Stem Cell Patents". Science. 313 (5785): 281. doi:10.1126/science.313.5785.281. PMID 16857907. S2CID 167760607.
- Eli Kintisch (18 July 2006). "Groups Target Stem Cell Patents". Science.
- Loring, Jeanne (8 November 2007). "A patent challenge for human embryonic stem cell research". Nature Reports Stem Cells. doi:10.1038/stemcells.2007.113.

edgar-online.com

yahoo.brand.edgar-online.com

"SEC Schedule 13G, filed Feb. 17, 1999". Archived from the original on 2016-03-06. Retrieved 2013-08-28.

escholarship.org

Keirstead HS, Nistor G, Bernal G, et al. (May 2005). "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury". J. Neurosci. 25 (19): 4694–705. doi:10.1523/JNEUROSCI.0311-05.2005. PMC 6724772. PMID 15888645.

fiercebiotech.com

"Geron shares crater as Janssen bows out of imetelstat pact once worth up to $935M". FierceBiotech. Retrieved 2021-01-05.

fool.com

Alex Planes (November 3, 2014). "Why Geron Corporation Shares Skyrocketed". The Motley Fool.

forbes.com

"Despite Bush Veto, Stem Cell Research Abounds – Forbes.com". Forbes. Archived from the original on February 4, 2007.
Herper, Matthew (April 5, 2001). "Geron's Cloning Quandary – Forbes.com". Forbes.

genengnews.com

News: Geron Presents New Data That Document Progress in Development of Therapeutic Products from Human Embryonic Stem Cells. Genetic Engineering & Biotechnology News – Biotechnology from Bench to Business

genetics-and-society.org

"Stem Cell Patents Come Under Fire". Center for Genetics and Society. Associated Press. 19 July 2006.

geron.com

ir.geron.com

"Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat". Investor Relations: Press Release. Geron. Archived from the original on September 5, 2015. Retrieved 2018-02-25.

globenewswire.com

Corporation, Geron. "Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk myelodysplastic syndromes". GlobeNewswire News Room. Retrieved 2018-02-25.

gpo.gov

"House Hearing, 107th Congress – The Human Cloning Prohibition Act of 2001 and The Cloning Prohibition Act of 2001", U.S. Government Publishing Office, 20 June 2001

harvard.edu

ui.adsabs.harvard.edu

Brennan, Sarah K.; Wang, Qiuju; Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina; Huff, Carol Ann; Jones, Richard J.; Matsui, William; Swarbrick, Alexander (1 September 2010). "Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms". PLOS ONE. 5 (9): e12487. Bibcode:2010PLoSO...512487B. doi:10.1371/journal.pone.0012487. PMC 2931698. PMID 20824134.
Borrell, Brendan (2 August 2012). "Lawsuit challenges anti-ageing claims". Nature. 488 (7409): 18. Bibcode:2012Natur.488...18B. doi:10.1038/488018a. PMID 22859181.

latimes.com

Monmaney, Terence (14 January 1998). "Scientists Give Cell Apparent Immortality". Los Angeles Times.

mercurynews.com

"Human tests of Geron's spinal-cord medication put on hold". The Mercury News. 2009-08-18. Retrieved 2020-04-29.

money.com

Salisbury, Ian (May 29, 2018). "This Map Shows the Best-Paying Company In Every State". Money.com. Archived from the original on September 30, 2020.

nature.com

"Funding windfall rescues abandoned stem-cell trial". Nature. June 3, 2014.
Loring, Jeanne (8 November 2007). "A patent challenge for human embryonic stem cell research". Nature Reports Stem Cells. doi:10.1038/stemcells.2007.113.

newscientist.com

"Anti-ageing drugs are coming that could keep you healthier for longer". New Scientist. April 24, 2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hayflick L (1965). "The limited in vitro lifetime of human diploid cell strains". Experimental Cell Research. 37 (3): 614–636. doi:10.1016/0014-4827(65)90211-9. PMID 14315085.
Brennan, Sarah K.; Wang, Qiuju; Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina; Huff, Carol Ann; Jones, Richard J.; Matsui, William; Swarbrick, Alexander (1 September 2010). "Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms". PLOS ONE. 5 (9): e12487. Bibcode:2010PLoSO...512487B. doi:10.1371/journal.pone.0012487. PMC 2931698. PMID 20824134.
Harley, Calvin B. (March 2008). "Telomerase and cancer therapeutics". Nature Reviews Cancer. 8 (3): 167–179. doi:10.1038/nrc2275. PMID 18256617. S2CID 39599576.
Fauce, Steven Russell; Jamieson, Beth D.; Chin, Allison C.; Mitsuyasu, Ronald T.; Parish, Stan T.; Ng, Hwee L.; Ramirez Kitchen, Christina M.; Yang, Otto O.; Harley, Calvin B.; Effros, Rita B. (2008). "Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8⁺ T Lymphocytes". The Journal of Immunology. 181 (10): 7400–7406. doi:10.4049/jimmunol.181.10.7400. PMC 2682219. PMID 18981163.
Borrell, Brendan (2 August 2012). "Lawsuit challenges anti-ageing claims". Nature. 488 (7409): 18. Bibcode:2012Natur.488...18B. doi:10.1038/488018a. PMID 22859181.
Keirstead HS, Nistor G, Bernal G, et al. (May 2005). "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury". J. Neurosci. 25 (19): 4694–705. doi:10.1523/JNEUROSCI.0311-05.2005. PMC 6724772. PMID 15888645.
Kintisch, E. (21 July 2006). "Groups Challenge Key Stem Cell Patents". Science. 313 (5785): 281. doi:10.1126/science.313.5785.281. PMID 16857907. S2CID 167760607.
- Eli Kintisch (18 July 2006). "Groups Target Stem Cell Patents". Science.
ncbi.nlm.nih.gov
- Brennan, Sarah K.; Wang, Qiuju; Tressler, Robert; Harley, Calvin; Go, Ning; Bassett, Ekaterina; Huff, Carol Ann; Jones, Richard J.; Matsui, William; Swarbrick, Alexander (1 September 2010). "Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms". PLOS ONE. 5 (9): e12487. Bibcode:2010PLoSO...512487B. doi:10.1371/journal.pone.0012487. PMC 2931698. PMID 20824134.
- Fauce, Steven Russell; Jamieson, Beth D.; Chin, Allison C.; Mitsuyasu, Ronald T.; Parish, Stan T.; Ng, Hwee L.; Ramirez Kitchen, Christina M.; Yang, Otto O.; Harley, Calvin B.; Effros, Rita B. (2008). "Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8⁺ T Lymphocytes". The Journal of Immunology. 181 (10): 7400–7406. doi:10.4049/jimmunol.181.10.7400. PMC 2682219. PMID 18981163.
- Keirstead HS, Nistor G, Bernal G, et al. (May 2005). "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury". J. Neurosci. 25 (19): 4694–705. doi:10.1523/JNEUROSCI.0311-05.2005. PMC 6724772. PMID 15888645.

nytimes.com

Pollack, Andrew (May 18, 2011). "A Blood Test Offers Clues to Longevity". New York Times.
Binstock, Robert H. (2003-07-22). "BOOKS OF THE TIMES; Quest for Infinite Youth Raises Hopes and Cash". The New York Times. ISSN 0362-4331. Retrieved 2020-04-29.

pubpat.org

"Wisconsin Group Eases Stem Cell Patent Restrictions After FTCR". PUBPAT. 23 January 2007. Retrieved 5 September 2013.

sandiegouniontribune.com

legacy.sandiegouniontribune.com

Somers, Terri (23 January 2007). "Stem cell scientists shout out hallelujah". The San Diego Union-Tribune.

science.org

Kintisch, E. (21 July 2006). "Groups Challenge Key Stem Cell Patents". Science. 313 (5785): 281. doi:10.1126/science.313.5785.281. PMID 16857907. S2CID 167760607.
- Eli Kintisch (18 July 2006). "Groups Target Stem Cell Patents". Science.

scimitarequity.com

"Geron (GERN) updates Clinical Data from GRNOPC1 Spinal Cord Injury Trial". 20 Oct 2011. Archived from the original on 2011-10-23.

sec.report

"Geron 2021 10K Annual Report". U.S. Securities and Exchange Commission. Retrieved 9 May 2022.

semanticscholar.org

api.semanticscholar.org

Harley, Calvin B. (March 2008). "Telomerase and cancer therapeutics". Nature Reviews Cancer. 8 (3): 167–179. doi:10.1038/nrc2275. PMID 18256617. S2CID 39599576.
Kintisch, E. (21 July 2006). "Groups Challenge Key Stem Cell Patents". Science. 313 (5785): 281. doi:10.1126/science.313.5785.281. PMID 16857907. S2CID 167760607.
- Eli Kintisch (18 July 2006). "Groups Target Stem Cell Patents". Science.

the-scientist.com

"Geron's Stem Cell Program Sold". The Scientist. October 2, 2013.

warf.org

"WARF press release". Archived from the original on 2008-09-22. Retrieved 2008-10-02.

web.archive.org

"SEC Schedule 13G, filed Feb. 17, 1999". Archived from the original on 2016-03-06. Retrieved 2013-08-28.
Salisbury, Ian (May 29, 2018). "This Map Shows the Best-Paying Company In Every State". Money.com. Archived from the original on September 30, 2020.
"Despite Bush Veto, Stem Cell Research Abounds – Forbes.com". Forbes. Archived from the original on February 4, 2007.
"Geron (GERN) updates Clinical Data from GRNOPC1 Spinal Cord Injury Trial". 20 Oct 2011. Archived from the original on 2011-10-23.
"WARF press release". Archived from the original on 2008-09-22. Retrieved 2008-10-02.
"Online Extra: Thomas Okarma: Don't Ban Stem-Cell Research". BusinessWeek. 2 June 2003. Archived from the original on 22 May 2011.

worldcat.org

search.worldcat.org

Binstock, Robert H. (2003-07-22). "BOOKS OF THE TIMES; Quest for Infinite Youth Raises Hopes and Cash". The New York Times. ISSN 0362-4331. Retrieved 2020-04-29.

wsj.com

Regalado, Antonio; Hamilton, David P. (18 July 2006). "How a University's Patents May Limit Stem-Cell Research". Wall Street Journal.

yahoo.com

finance.yahoo.com

"Geron Announces Record Date for Distribution of Asterias Series A Common Stock". Yahoo Finance. Retrieved 15 November 2016.

zacks.com

"Geron Scraps GRN1005, Cuts Jobs". Zacks Investment Research. Retrieved 15 November 2016.